SCHEMBL7987785

SCHEMBL7987785

CCc1nc(=O)c2c(ncn2Cc2ccc(OCc3ccccc3)cc2)[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARN O95453 1/20 0.47
CNOT7 Q9UIV1 1/20 0.47
BRD4 O60885 2/20 0.46
NPC1 O15118 3/20 0.42
TP53 P04637 2/20 0.42
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
RAB9A P51151 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
FAAH O00519 1/20 0.41
MGLL Q99685 1/20 0.41
MAPK14 Q16539 2/20 0.40
HPGD P15428 1/20 0.40
GRM2 Q14416 1/20 0.40
PNP P00491 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7975254 0.90 CNOT7 (0.55) PARNCNOT7BRD4ALDH1A1SMN1; SMN2
SCHEMBL7973938 0.86 CNOT7 (0.48) PARNCNOT7BRD4TP53ALDH1A1
SCHEMBL7987444 0.85 PARN (0.42) PARNCNOT7BRD4NPC1ALDH1A1
SCHEMBL7988132 0.83 CNOT7 (0.44) PARNCNOT7BRD4ALDH1A1SMN1; SMN2
SCHEMBL7987778 0.83 ALDH1A1 (0.51) BRD4NPC1TP53ALDH1A1SMN1; SMN2
SCHEMBL7985654 0.83 CNOT7 (0.42) PARNCNOT7ALDH1A1SMN1; SMN2FAAH
SCHEMBL7992340 0.82 CNOT7 (0.40) PARNCNOT7BRD4NPC1ALDH1A1
SCHEMBL7985346 0.82 CNOT7 (0.52) PARNCNOT7BRD4ALDH1A1SMN1; SMN2
SCHEMBL7987439 0.82 CNOT7 (0.43) PARNCNOT7BRD4TP53ALDH1A1
SCHEMBL7974521 0.82 ADORA3 (0.48) PARNCNOT7ALDH1A1KDM4ENPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed